# JPMORGAN CHASE & CO (JPM) · Edgar & Edgarette company card

> Jpmorgan Chase & (JPM) grew revenue 2.8% in FY2025 to $182.4 billion, equity 8.2% of assets, and dividend per share up 15 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 19617 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/JPM) · [JSON](https://www.pops4.com/boards/company/JPM.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $182.4B |
| Revenue growth, 1 year | 2.8% |
| Revenue growth per year | 10.7% |
| Operating margin | — |
| Net margin | 31.3% |
| Operating cash flow | −$147.8B |
| Capital spending | — |
| Free cash flow | — |
| Cash | $343.3B |
| Long-term debt | $435.2B |
| Total assets | $4424.9B |
| Total equity | $362.4B |
| Equity ÷ assets | 8.2% |
| Return on equity | 15.7% |
| Dividend per share | $5.8 |
| Dividend years rising | 15 |

## Readings, computed from those figures

- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Sound ship · one warning sign · operating cash flow was negative
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $182.4B (FY2025), total debt $435.2B. Experience: revenue up 2.8% on the year, up 10.7% a year over 4 years. Soundness: equity 8.2% of assets, return on equity 15.7%, payout 29.1% of profit, dividend per share up 15 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $171.7B and $209.4B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $157.3B to $226.7B. A statistical range, not company guidance. Against peers (20 filers, $50M+ revenue, national commercial banks): growth 2.8% against 7.2%.

Range logged 2026-09-26, receipt ee2561b26035af78, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-06-25 ([filing](https://www.sec.gov/Archives/edgar/data/19617/000001961726000241/0000019617-26-000241-index.htm))

## Recent filings

- 10-Q · filed 2026-11-03 · [filing](https://www.sec.gov/Archives/edgar/data/19617/000162828026069523/0001628280-26-069523-index.htm)
- 8-K · filed 2026-10-20 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/19617/000119312526426704/0001193125-26-426704-index.htm)
- 8-K · filed 2026-10-13 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/19617/000162828026065616/0001628280-26-065616-index.htm)
- 8-K · filed 2026-10-13 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/19617/000162828026065582/0001628280-26-065582-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/19617/000162828026054343/0001628280-26-054343-index.htm)
- 8-K · filed 2026-07-23 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/19617/000119312526314128/0001193125-26-314128-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000019617.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=19617

## Cite

POPS4, Edgar & Edgarette: JPMORGAN CHASE & CO (JPM) company card, from the company's own SEC filings, accessed 2026-11-10, https://www.pops4.com/boards/company/JPM. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.